 Novan Inc. NASDAQ: NOVN shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events. The stock was trending throughout the day on StockTwits and was trading on higher than average volume. 